List of Excipients in API carglumic acid
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing carglumic acid
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Recordati Rare Diseases | CARBAGLU | carglumic acid | 52276-312 | CELLULOSE, MICROCRYSTALLINE | |
Recordati Rare Diseases | CARBAGLU | carglumic acid | 52276-312 | CROSCARMELLOSE SODIUM | |
Recordati Rare Diseases | CARBAGLU | carglumic acid | 52276-312 | HYPROMELLOSE | |
Recordati Rare Diseases | CARBAGLU | carglumic acid | 52276-312 | SILICON DIOXIDE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing carglumic acid
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 | CELLULOSE, MICROCRYSTALLINE |
Navinta LLC | carglumic acid | 68475-006 | CELLULOSE, MICROCRYSTALLINE |
Navinta LLC | carglumic acid | 68475-006 | CROSCARMELLOSE SODIUM |
Navinta LLC | carglumic acid | 68475-006 | MICROCRYSTALLINE CELLULOSE 105 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for carglumic acid
Excipient focus: CELLULOSE, MICROCRYSTALLINE
carglumic acid drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
Recordati Rare Diseases | carglumic acid | 52276-312 |
Navinta LLC | carglumic acid | 68475-006 |
Novitium Pharma LLC | carglumic acid | 70954-120 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
carglumic acid drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Recordati Rare Diseases | carglumic acid | 52276-312 |
Navinta LLC | carglumic acid | 68475-006 |
Novitium Pharma LLC | carglumic acid | 70954-120 |
Eton Pharmaceuticals Inc | carglumic acid | 71863-114 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
carglumic acid drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Recordati Rare Diseases | carglumic acid | 52276-312 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
Navinta LLC | carglumic acid | 68475-006 |
Novitium Pharma LLC | carglumic acid | 70954-120 |
Eton Pharmaceuticals Inc | carglumic acid | 71863-114 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
carglumic acid drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Novitium Pharma LLC | carglumic acid | 70954-120 |
Eton Pharmaceuticals Inc | carglumic acid | 71863-114 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
Recordati Rare Diseases | carglumic acid | 52276-312 |
Navinta LLC | carglumic acid | 68475-006 |
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
carglumic acid drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Novitium Pharma LLC | carglumic acid | 70954-120 |
Eton Pharmaceuticals Inc | carglumic acid | 71863-114 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
Recordati Rare Diseases | carglumic acid | 52276-312 |
Navinta LLC | carglumic acid | 68475-006 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 105
carglumic acid drug variants containing MICROCRYSTALLINE CELLULOSE 105
Company | Ingredient | NDC |
---|---|---|
Navinta LLC | carglumic acid | 68475-006 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing MICROCRYSTALLINE CELLULOSE 105
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
Recordati Rare Diseases | carglumic acid | 52276-312 |
Novitium Pharma LLC | carglumic acid | 70954-120 |
Eton Pharmaceuticals Inc | carglumic acid | 71863-114 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
carglumic acid drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Novitium Pharma LLC | carglumic acid | 70954-120 |
Eton Pharmaceuticals Inc | carglumic acid | 71863-114 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
Recordati Rare Diseases | carglumic acid | 52276-312 |
Navinta LLC | carglumic acid | 68475-006 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
carglumic acid drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Recordati Rare Diseases | carglumic acid | 52276-312 |
Navinta LLC | carglumic acid | 68475-006 |
Novitium Pharma LLC | carglumic acid | 70954-120 |
Eton Pharmaceuticals Inc | carglumic acid | 71863-114 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
carglumic acid drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Recordati Rare Diseases | carglumic acid | 52276-312 |
Navinta LLC | carglumic acid | 68475-006 |
Novitium Pharma LLC | carglumic acid | 70954-120 |
Eton Pharmaceuticals Inc | carglumic acid | 71863-114 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
carglumic acid drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Recordati Rare Diseases | carglumic acid | 52276-312 |
Navinta LLC | carglumic acid | 68475-006 |
Novitium Pharma LLC | carglumic acid | 70954-120 |
Eton Pharmaceuticals Inc | carglumic acid | 71863-114 |
>Company | >Ingredient | >NDC |
carglumic acid drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Burel Pharmaceuticals LLC | carglumic acid | 35573-459 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.